MJA
MJA InSight
MJA Careers
Letters

Regressing metastatic melanoma and vitiligo-like depigmentation in an Indigenous Australian

Elizabeth M Christou, Diona L Damian and John F Thompson
Med J Aust 2010; 192 (3): 171.

To the Editor: A 69-year-old Indigenous Australian man, with no known Caucasian ancestry, presented in 2008 with a 7-week history of depigmentation of the face and neck, which was initially intensely pruritic and erythematous.

Elizabeth M Christou, Dermatology Registrar1
Diona L Damian, Dermatologist1,2
John F Thompson, Surgical Oncologist1,2,3
1 Royal Prince Alfred Hospital, Sydney, NSW.
2 University of Sydney, Sydney, NSW.
3 Melanoma Institute Australia, Sydney, NSW.
Article References: 
Reference Text: 
Lendon AH, Bennett RC. Malignant melanoma in an Aboriginal. Med J Aust 1972; 2: 1486-1487.
Reference Order: 
1
PubMed ID: 
4655128
Reference Text: 
Pearce RL. Subungual desmoplastic melanoma in an Aboriginal woman. Med J Aust 1995; 162: 611-612.
Reference Order: 
2
PubMed ID: 
7791651
Reference Text: 
Ram M, Shoenfeld Y. Harnessing autoimmunity (vitiligo) to treat melanoma: a myth or reality? Ann N Y Acad Sci 2007; 1110: 410-425.
Reference Order: 
3
PubMed ID: 
17911456
Reference Text: 
Quaglino P, Marenco F, Osella-Abate S, et al. Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study. Ann Oncol. Epub 2009 Jul 21. http://annonc.oxfordjournals.org/cgi/content/abstract/mdp325 (abstract accessed Dec 2009).
Reference Order: 
4
PubMed ID: 

The full contents of this page are only available to subscribers.